Never stop advancing – incremental innovation
This video illustrates the value of innovation — both revolutionary and incremental — in the biopharmaceutical field. With a specific focus on incremental innovation, it explains how the continuous investments in R&D, and consequent advances in available treatments, have bettered the lives of millions patients all around the world.
About IFPMA
The International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) represents over 90 innovative pharmaceutical companies and associations across the globe. Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community improve the lives of people everywhere. The industry’s two million employees discover, develop, and deliver medicines and vaccines that advance global health.
Learn more
Related news and resources
Collaborating for Global Health Progress flyer
Discover how the innovative pharmaceutical industry works with partners to advance the SDGs
Read more
WHO Intergovernmental Negotiating Body (INB) intersessional briefing on the “Transfer of technology and know-how”
On 20 March, IFPMA delivered a shortened version of the below statement at the WHO INB intersessional briefing on “Article 7: Access to technology: promoting sustainable and equitably distributed production and transfer of technology and know-how” of the WHO convention, agreement, or other international instrument on pandemic prevention, preparedness, and response (“WHO CA+”).
Read moreStatement to the IHR Review Committee on amendments to the International Health Regulations
IFPMA encourages the consistent coordination of the INB and IHR processes to ensure a non-duplicative, fit-for-purpose outcome for all.
Read more